» Articles » PMID: 25697881

Epidemiology of Augmented Renal Clearance in Mixed ICU Patients

Overview
Specialty Anesthesiology
Date 2015 Feb 21
PMID 25697881
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Augmented renal clearance (ARC) or renal hyperfiltration is increasingly reported in intensive care unit (ICU) patients. The goal of this analysis was to study the epidemiology of ARC in a cohort of mixed ICU patients

Methods: Single center retrospective cohort study of adult ICU patients (12/2008-2/2010). When data were available, urinary creatinine clearance (CLCR) was calculated for all patients throughout their ICU stay. ARC was defined as a body surface adjusted CLCR≥130 mL/min/1.73m2. We sought to study the incidence of ARC and identify patient characteristics associated with ARC.

Results: A total of 1081 patients were included in the analysis, generating 4472 ICU patient days. Median age was 62 y (IQR 50-72), and 63% were male. The initial CLCR was 86 (39-151) mL/min and the maximal CLCR was 145 (76-237) mL/min. ARC occurred in 55.8% of patients, and was about as frequent in men and women (37%% vs. 35%%, P=0.73). Patients with ARC were younger (57 vs. 67 years, P<0.001) and were less frequently treated with vasopressors (27% vs. 39%, P<0.01). ARC incidence was 36.6 ARC days per 100 ICU days. ARC throughout the ICU stay occurred in 32.8% of patients.

Conclusion: ARC was a frequent finding in this cohort of ICU patients, with more than half of the patient expressing ARC at least once during their ICU stay, and an incidence of 36.6 ARC days/100 patient days.

Citing Articles

Augmented Renal Clearance: Prevalence, Risk Factors and Underlying Mechanism in Critically Ill Patients with Subarachnoid Hemorrhage.

de Courson H, Cane G, dAuzac A, Barbieri A, Derot S, Carrie C Neurocrit Care. 2024; .

PMID: 39511114 DOI: 10.1007/s12028-024-02144-6.


Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.

Wu Y, Lu Z, Liang P, Zhu H, Qi H, Zhang H Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(7):4791-4798.

PMID: 38153513 DOI: 10.1007/s00210-023-02909-4.


Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children.

Dhont E, Van Der Heggen T, Snauwaert E, Willems J, Croubels S, Delanghe J Pediatr Nephrol. 2023; 39(5):1607-1616.

PMID: 37994980 DOI: 10.1007/s00467-023-06221-4.


The Good, the Bad, and the Serum Creatinine: Exploring the Effect of Muscle Mass and Nutrition.

De Rosa S, Greco M, Rauseo M, Annetta M Blood Purif. 2023; 52(9-10):775-785.

PMID: 37742621 PMC: 10623400. DOI: 10.1159/000533173.


LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance.

Wang Y, Luo Y, Yang S, Jiang M, Chu Y Int J Mol Sci. 2023; 24(13).

PMID: 37445637 PMC: 10341629. DOI: 10.3390/ijms241310459.